Ascendis Pharma (ASND) Prices 2.5M ADS Offering at $160/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Ascendis Pharma (ASND) Prices 2.5M ADS Offering at $160/sh

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

September 1, 2021 7:43 PM EDT

COPENHAGEN, Denmark, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to potentially create new treatments that make a meaningful difference in patients lives, today announced the pricing of its underwritten public offering of 2,500,000 American Depositary Shares (ADSs), each of which represents one ordinary share of Ascendis, at a price to the public of $160.00 per ADS. All of the ADSs are being offered by Ascendis. The offering is expected to close on or about September 7, 2021 subject to customary closing conditions. In addition, Ascendis has granted the... More